The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.
Full MCap of at least 150 mln USD. Three month average-daily-trading volume of at least 1 mln USD at a review and also at the previous two reviews. At least 250,000 shares traded per month over the last six months at a review and also at the previous two reviews.
Companies have to generate at least 50% revenues from pharmaceuticals.
Company weightings are capped at 20%.
Semi-annually with quarterly rebalances.
1,487.10 - 2,637.89
1,768.41 - 3,266.29
2,166.91 - 3,971.25
MVIS® US Listed Pharmaceutical 25 Price Index
MVIS® US Listed Pharmaceutical 25 Total Return Gross Index
MVIS® US Listed Pharmaceutical 25 Total Return Net Index
NEWS & RESEARCH
Gain access to all Index Data and receive updates on market developments, index news and corporate announcements.